Editor’s note: This series profiles five of the Seattle region’s “Uncommon Thinkers”: inventors, scientists, technologists and entrepreneurs transforming industries and driving positive… Read More
Four national cancer research organizations, spearheaded by Seattle’s Fred Hutch Cancer Center, will work together in an unprecedented alliance to… Read More
Researchers at Microsoft, Providence Health System and the University of Washington say they’ve developed a new artificial intelligence model for… Read More
Seattle biotech company Phase Genomics announced Wednesday that it received two National Institutes of Health (NIH) grants totaling $3.9 million.… Read More
Researchers at Seattle’s Fred Hutchinson Cancer Research Center have demonstrated the effectiveness of a new method for getting immune cells… Read More
New funding: Concure Oncology is raising investment for its Breast Microseed treatment, which helps to prevent breast cancer from recurring.… Read More
Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering.… Read More
Vancouver, B.C.-based Aquinox Pharmaceuticals is set to buy Neoleukin Therapeutics, a Seattle startup that launched out of the University of… Read More
The Fred Hutchinson Cancer Research Center in Seattle wants to raise awareness about colorectal health in underserved communities across Washington… Read More